SCM
IART icon

Soleus Capital Management’s Integra LifeSciences IART Stock Holding History

Soleus Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,440,818
Closed -$20.6M – 106
2025
Q3 		$20.6M Buy
1,440,818
+53,000
+4% +$726K 1.04% 27
2025
Q2 		$17M Buy
1,387,818
+315,614
+29% +$4.58M 1.13% 27
2025
Q1 		$23.6M Sell
1,072,204
-203,796
-16% -$4.79M 1.7% 18
2024
Q4 		$28.9M Buy
+1,276,000
New +$27.9M 1.82% 17

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Soleus Capital Management's IART Position: Q4 2025 in Review

Soleus Capital Management sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 1,440,818 shares — an estimated $20.6M sold.

Soleus Capital Management first reported a position in IART in Q4 2024 and held it in 4 quarters. The position peaked at $28.9M in Q4 2024. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • Soleus Capital Management reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
  • Soleus Capital Management sold 1,440,818 Integra LifeSciences shares in Q4 2025, an estimated $20.6M.
  • Soleus Capital Management first reported a position in Integra LifeSciences in Q4 2024 and held it in 4 quarters.
  • Soleus Capital Management's Integra LifeSciences position peaked at $28.9M in Q4 2024.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Soleus Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.